Standards of clinical practice for renal pharmacists.
作者信息
Raymond Colette B, Wazny Lori D, Sood Amy R
机构信息
, PharmD, MSc, ACPR, was, at the time of writing, with the Winnipeg Regional Health Authority Pharmacy Program, Department of Pharmaceutical Services, Health Sciences Centre, Winnipeg, Manitoba. She is now with the Department of Pharmacy, University Health Network, and the Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario.
, PharmD, is with the Winnipeg Regional Health Authority Pharmacy Program, Department of Pharmaceutical Services, Health Sciences Centre, Winnipeg, Manitoba.
出版信息
Can J Hosp Pharm. 2013 Nov;66(6):369-74. doi: 10.4212/cjhp.v66i6.1302.
Abstract
摘要
相似文献
1
Standards of clinical practice for renal pharmacists.
Can J Hosp Pharm. 2013 Nov;66(6):369-74. doi: 10.4212/cjhp.v66i6.1302.
2
Pharmacists' perceptions of a set of pharmaceutical care practice standards.
J Am Pharm Assoc (Wash). 1997 Sep-Oct;NS37(5):529-34. doi: 10.1016/s1086-5802(16)30246-7.
3
Use of professional practice guidance resources in pharmacy: a cross-sectional nationwide survey of pharmacists, intern pharmacists, and pharmacy students.
J Pharm Policy Pract. 2021 Dec 29;14(1):114. doi: 10.1186/s40545-021-00395-8.
4
An evaluation of the integration of standards and guidelines in community pharmacy practices.
Pharm World Sci. 2009 Oct;31(5):542-549. doi: 10.1007/s11096-009-9309-9. Epub 2009 Jul 5.
5
Community pharmacists and Colleges of Pharmacy: the Ohio partnership.
J Am Pharm Assoc (2003). 2005 Jan-Feb;45(1):82-7. doi: 10.1331/1544345052843057.
6
Standards of practice for clinical pharmacists: the time has come.
Pharmacotherapy. 2014 Aug;34(8):769-70. doi: 10.1002/phar.1450.
7
U.S. clinicians' and pharmacists' reported barriers to implementation of the Standards for Adult Immunization Practice.
Vaccine. 2018 Oct 29;36(45):6772-6781. doi: 10.1016/j.vaccine.2018.09.024. Epub 2018 Sep 20.
8
Knowledge, use and perceived relevance of a profession's Competency Standards; implications for Pharmacy Education.
Int J Pharm Pract. 2016 Dec;24(6):390-402. doi: 10.1111/ijpp.12267. Epub 2016 Apr 21.
9
Pharmacists' Knowledge and Perceptions of FDA Approval Standards and the Breakthrough Therapy Designation.
Pharmacy (Basel). 2022 Sep 30;10(5):126. doi: 10.3390/pharmacy10050126.
10
Do pharmacy practice standards effectively describe behaviour? Reviewing practice standards using a behavioural specificity framework.
BMC Health Serv Res. 2022 Jan 14;22(1):71. doi: 10.1186/s12913-021-07358-4.
引用本文的文献
1
Intermittent hemodialysis: a review of the top antimicrobial stewardship practices to be employed.
Antimicrob Steward Healthc Epidemiol. 2024 Jan 11;4(1):e2. doi: 10.1017/ash.2023.525. eCollection 2024.
2
Comparison of Drug-Related Problems in COVID-19 and Non-COVID-19 Patients Provided by a German Telepharmacy Service for Rural Intensive Care Units.
J Clin Med. 2023 Jul 18;12(14):4739. doi: 10.3390/jcm12144739.
3
Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.
PLoS One. 2022 Dec 22;17(12):e0278648. doi: 10.1371/journal.pone.0278648. eCollection 2022.
4
Pharmacy Practice Standards for Outpatient Nephrology Settings.
Kidney Med. 2022 Jun 26;4(8):100509. doi: 10.1016/j.xkme.2022.100509. eCollection 2022 Aug.
5
The standards of practice for delivery of polypharmacy and chronic disease medication reviews by general practice clinical pharmacists: a consensus study.
Int J Clin Pharm. 2022 Jun;44(3):663-672. doi: 10.1007/s11096-022-01387-7. Epub 2022 Mar 23.
6
Assessment of Pharmacists' Knowledge and Practices towards Prescribed Medications for Dialysis Patients at a Tertiary Hospital in Riyadh Saudi Arabia.
Healthcare (Basel). 2021 Aug 25;9(9):1098. doi: 10.3390/healthcare9091098.
7
Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis.
Am J Kidney Dis. 2020 Dec;76(6):868-876. doi: 10.1053/j.ajkd.2020.07.021. Epub 2020 Sep 10.
8
Redefining Medication Management in Dialysis: A Kidney Pharmacy Quality Pyramid.
Kidney Med. 2019 Aug 20;1(5):307-314. doi: 10.1016/j.xkme.2019.06.008. eCollection 2019 Sep-Oct.
9
Barriers to and Enablers of Implementation of High-Value Interventions by Renal Pharmacists: A Qualitative Study Informed by the Theoretical Domains Framework.
Can J Hosp Pharm. 2020 May-Jun;73(3):177-185. Epub 2020 Jun 1.
10
Pharmacotherapy assessment in chronic kidney disease: validation of the PAIR instrument for use in Brazil.
J Bras Nefrol. 2020 Oct-Dec;42(4):400-412. doi: 10.1590/2175-8239-JBN-2019-0205.
本文引用的文献
1
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Introduction.
Can J Diabetes. 2013 Apr;37 Suppl 1:S1-3. doi: 10.1016/j.jcjd.2013.01.009. Epub 2013 Mar 26.
2
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update.
Am J Kidney Dis. 2012 Nov;60(5):850-86. doi: 10.1053/j.ajkd.2012.07.005.
3
Management of gouty arthritis in patients with chronic kidney disease.
Am J Ther. 2014 Nov-Dec;21(6):523-34. doi: 10.1097/MJT.0b013e318250f83d.
4
Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Clin Infect Dis. 2012 Aug;55(4):527-33. doi: 10.1093/cid/cis458. Epub 2012 May 9.
5
Treatment of leg cramps in patients with chronic kidney disease receiving hemodialysis.
CANNT J. 2011 Jul-Sep;21(3):19-21; quiz 22-3.
6
A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease.
Kidney Int. 2012 Feb;81(3):247-55. doi: 10.1038/ki.2011.358. Epub 2011 Oct 19.
7
Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
Kidney Int. 2011 Dec;80(11):1122-37. doi: 10.1038/ki.2011.322. Epub 2011 Sep 14.
8
Medication adherence in patients with chronic kidney disease.
CANNT J. 2011 Apr-Jun;21(2):47-50; quiz 51-2.
9
Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.
Am J Kidney Dis. 2011 Oct;58(4):527-35. doi: 10.1053/j.ajkd.2011.04.020. Epub 2011 Jul 20.
10
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
Kidney Int. 2011 Sep;80(6):572-86. doi: 10.1038/ki.2011.223. Epub 2011 Jul 13.
Zotero 插件